Table 3

Schedule of enrolment, interventions and assessments

	Study period
	Enrolment	Allocation	Post-allocation			Close-out
Timepoint	−t₂	−t₁	t₁	t₂	t₃	t₄
Enrolment
Eligibility screen	X
Informed consent	X
Allocation		X
Interventions
CGA-based multicomponent intervention
Assessments
Primary outcomes (clinical effectiveness)					X^a
Secondary outcomes	X^b−1		X^b−2	X^b−3	X^b−4	X^a, X^b−5
Economic evaluation				X^c	X^c

t₁, baseline (before intervention measurement); t₂, discharge (after intervention measurement); t₃, follow-up measurement (3 months after discharge); t₄, follow-up measurement (6 months after discharge); X^a, living at home; X^b−1: frailty; X^b−2, quality of life, recognition of advance directive and changes in sarcopenic obesity, activity of daily living; X^b−3, medication management, length of hospital stay, geriatric syndrome during hospitalisation, readiness for hospital discharge, family interaction, connectedness, empowerment; X^b−4, quality of life, activity of daily living, overall treatment utility, recognition of advance directive and changes in sarcopenic obesity, healthcare utilisation, empowerment, frailty; X^b−5, overall treatment utility, recognition of advance directive and changes in sarcopenic obesity, healthcare utilisation, frailty; X^c, cost-effectiveness analysis.
CGA, comprehensive geriatric assessment.